Aiolos Bio
Kimberly Harrow is an experienced professional in clinical operations and life cycle management, currently serving as VP of Life Cycle Management at Aiolos Bio since April 2023. Prior to this role, Kimberly held the same position at Tier1 bio and served as VP of Clinical Operations at EQRx. With a robust background at Xcovery, Kimberly progressed from Startup Manager to Executive Director of Clinical Operations over a decade. Kimberly's career also includes a role as Director of Sales at MolecularMD and as an Account Manager at Upstate. Educational credentials include an MBA in Business Administration from the University of Florida and a Bachelor's degree in Biology from the same institution. Kimberly is dedicated to challenging inefficiencies in clinical development and building innovative teams.
Aiolos Bio
At Aiolos Bio, we are dedicated to revolutionizing the treatment landscape for respiratory disease and other immunological disorders. Our goal is to provide patients and caregivers with more efficacious therapies that significantly reduce treatment burden. Our vision is embodied in our current focus – the development of a groundbreaking anti-TSLP therapy with best-in-class potential. We are a San Francisco Bay area-based clinical stage biopharma company with additional operations in London, UK. The Aiolos team is comprised of seasoned drug developers, who have successfully developed and launched products for a range of immune conditions, including asthma, rheumatoid arthritis, IPF, and more. As we grow, we will look to add like-minded individuals to our team - those committed to the goal of providing a meaningful difference in the lives of patients suffering from respiratory illnesses and other immune disorders.